Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/1999
04/01/1999CA2303663A1 Expression of genes in hematopoietic stem cells in hischaemic conditions
04/01/1999CA2303528A1 New npy antagonists
04/01/1999CA2303487A1 Vitronectin receptor antagonists
04/01/1999CA2303405A1 53bp2 complexes
04/01/1999CA2303359A1 1,5-diphenylpyrazole derivatives
04/01/1999CA2303147A1 Small particle liposome aerosols for delivery of anti-cancer drugs
04/01/1999CA2303096A1 Binuclear complex
04/01/1999CA2302993A1 Mutants of thyroid stimulating hormone and methods based thereon
04/01/1999CA2302936A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
04/01/1999CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/1999CA2301957A1 Antisense oligonucleotides against thymidylate synthase
04/01/1999CA2246004A1 A kringle-related clone, hthbz47
03/1999
03/31/1999EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA
03/31/1999EP0905236A1 Transcription factor DP-1
03/31/1999EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them
03/31/1999EP0905130A1 A process for the production of taxol
03/31/1999EP0905126A1 Metalloproteinase inhibitors
03/31/1999EP0904539A1 Inhibiting protein interactions
03/31/1999EP0904394A1 Chicken embryo lethal orphan (celo) virus
03/31/1999EP0904366A1 Apo-2li and apo-3 apoptosis polypeptides
03/31/1999EP0904299A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
03/31/1999EP0904291A2 Antipathogenic peptides and compositions comprising them
03/31/1999EP0904285A1 Cyclic adhesion inhibitors
03/31/1999EP0904284A1 6-substituted amino-4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as cysteine protease inhibitors
03/31/1999EP0904274A1 Farnesyl transferase inhibitors
03/31/1999EP0904271A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
03/31/1999EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids
03/31/1999EP0904095A1 Chimeric isoprenoid synthases and uses thereof
03/31/1999EP0904087A1 Phosphatidic acid-comprising compositions
03/31/1999EP0904080A1 Inhibitors of farnesyl-protein transferase
03/31/1999EP0904076A1 Inhibitors of farnesyl-protein transferase
03/31/1999EP0904074A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases
03/31/1999EP0904073A1 Zwitterionic compositions and methods as biological response modifiers
03/31/1999EP0904069A1 Pla2 inhibitors of angiogenesis
03/31/1999EP0788492B1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
03/31/1999EP0733035B1 Tricyclic derivatives, pharmaceutical compositions containing them
03/31/1999EP0659752B1 Antibacterial and anti-tumor epoxide derivate dc 114-a1
03/31/1999CN1212701A Oligonucleotide analogues
03/31/1999CN1212696A Pyrimido [5,4-d] pyrimidines, medicaments containing these componds, their use and process for their production
03/31/1999CN1212695A 4-amino pyrimidine derivates, medicament containing these compounds, their use
03/31/1999CN1212694A Pyrimido [5,4-D] pyrimidines, medicaments containing these compounds, their use and process for their production
03/31/1999CN1212690A Novel piperidines derived from 1-(piperazin-1-yl) aryl (oxylamino) carbonyl/4-aryl-piperidine as selective 5-HTiD beta receptor antagonist
03/31/1999CN1212684A 4-anilinoquinazoline derivatives
03/31/1999CN1212623A Method for inducing death of neoplastic cells using piperazine oxirane derivatives
03/31/1999CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases
03/31/1999CN1212255A Biphenylsulfonyl cyanamides, process for their preparation, and their use as medicament
03/31/1999CN1212161A Anti-radioactivity fibration drug
03/30/1999US5889178 N-(2,2-diphenylethyl)-derivatives
03/30/1999US5889157 Humanized B3 antibody fragments, fusion proteins, and uses thereof
03/30/1999US5889156 TNF deletion muteins
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889053 Anticarcinogenic agents
03/30/1999US5889043 Esterification
03/30/1999US5889037 Prevention, therapy tissue damage from lipid peroxidation
03/30/1999US5889007 Chemisensitizing agents; cancer therapy drug resistance
03/30/1999US5888994 Anticancer agnets; antitumor agents; glandular disorders
03/30/1999US5888965 Method of stimulating bone marrow regeneration
03/30/1999US5888817 For breast and prostate cancer cells
03/30/1999US5888812 Myeloid cell leukemia associated gene MCL-1
03/30/1999US5888792 Encoded with polynucleotide sequence
03/30/1999US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
03/30/1999US5888506 A detergent free polypeptide in the form of crystal structure or lyophilized or conjugated with polyoxyethylene glycol and contains less than 1 ng endotoxin per mg protein
03/30/1999US5888473 Tumor therapy; boron cage compounds
03/30/1999CA2170608C 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
03/30/1999CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014326A1 Mage-3 peptides presented by hla class ii molecules
03/25/1999WO1999014321A1 Novel therapeutic molecules
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999WO1999014230A1 Mammaglobin, a secreted mammary-specific breast cancer protein
03/25/1999WO1999014226A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/25/1999WO1999014213A1 Substituted chroman derivatives
03/25/1999WO1999014209A1 New taxane derivatives
03/25/1999WO1999014207A1 Substituted indan derivatives
03/25/1999WO1999014205A1 New 2-(3h)-oxazolone derivatives
03/25/1999WO1999014195A1 2-aminopyridines as inhibitors of cyclooxygenase-2
03/25/1999WO1999013920A2 Method for treating proliferative diseases by therapy
03/25/1999WO1999013914A1 Pharmaceutical compositions containing plasma protein
03/25/1999WO1999013912A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
03/25/1999WO1999013910A1 Neovascularization inhibitor
03/25/1999WO1999013908A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999WO1999013873A1 Agent for treating patients suffering from tumours
03/25/1999WO1999013816A2 Liposomal camptothecin formulations
03/25/1999WO1999007383B1 Composition and method for regulating cell proliferation and cell death
03/25/1999WO1998050530A9 Enzymatic nucleic acids: synthesis, selection and use
03/25/1999WO1998042296A3 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304167A1 Mammaglobin, a secreted mammary-specific breast cancer protein
03/25/1999CA2304124A1 Bci-2-like protein bim and methods of use thereof
03/25/1999CA2304011A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999CA2303926A1 Substituted chroman derivatives
03/25/1999CA2303839A1 Substituted indan derivatives
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303366A1 Liposomal camptothecin formulations
03/25/1999CA2303299A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/25/1999CA2303227A1 Human prl-1 phosphatase
1 ... 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 ... 2211